MARINA KONOPLEVA, M.D. PHD
Osteopathic Medicine at Holcombe Blvd, Houston, TX
License number
Texas 41493
Category
Osteopathic Medicine
Type
Internal Medicine
Address
Address
1515 Holcombe Blvd, Houston, TX 77030
Phone
(713) 792-6161
(713) 792-2991
(713) 792-2991
Personal information
See more information about MARINA KONOPLEVA at radaris.comName
Address
Phone
2417 Dorrington St, Houston, TX 77030
4230 Amherst St, Houston, TX 77005
4252 Judson, Houston, TX 77005
Organization information
See more information about MARINA KONOPLEVA at bizstanding.comUt MD Anderson Cancer Center - Marina Konopleva MD
1515 Holcombe Blvd UNIT 207, Houston, TX 77030
Categories:
Internal Medicine Physicians & Surgeons
Phone:
(713) 792-6161 (Phone)
Professional information
See more information about MARINA KONOPLEVA at trustoria.com
Assist Prof At Md Anderson Cancer Center
Assist Prof At Md Anderson Cancer Center
Position:
Assist Prof at MD Anderson Cancer Center
Location:
Houston, Texas Area
Industry:
Medical Practice
Work:
MD Anderson Cancer Center
-
Assist Prof
Dr. Marina Konopleva - MD (Doctor of Medicine)
Dr. Marina Konopleva - MD (Doctor of Medicine)
Hospitals:
M.D. ANDERSON CANCER CENTER AT UNIVERSITY OF TEXAS
1515 Holcombe Blvd SUITE 428, Houston 77030
MD Anderson Cancer Ctr Leukemia
1400 Holcombe Blvd SUITE 463, Houston 77030
The University of Texas M.D. Anderson Cancer Center
1515 Holcombe Blvd, Houston 77030
M.D. ANDERSON CANCER CENTER AT UNIVERSITY OF TEXAS
1515 Holcombe Blvd SUITE 428, Houston 77030
MD Anderson Cancer Ctr Leukemia
1400 Holcombe Blvd SUITE 463, Houston 77030
The University of Texas M.D. Anderson Cancer Center
1515 Holcombe Blvd, Houston 77030
1515 Holcombe Blvd SUITE 428, Houston 77030
MD Anderson Cancer Ctr Leukemia
1400 Holcombe Blvd SUITE 463, Houston 77030
The University of Texas M.D. Anderson Cancer Center
1515 Holcombe Blvd, Houston 77030
M.D. ANDERSON CANCER CENTER AT UNIVERSITY OF TEXAS
1515 Holcombe Blvd SUITE 428, Houston 77030
MD Anderson Cancer Ctr Leukemia
1400 Holcombe Blvd SUITE 463, Houston 77030
The University of Texas M.D. Anderson Cancer Center
1515 Holcombe Blvd, Houston 77030
Education:
Medical Schools
Ip Pavlov Higher Medical Institute
Graduated: 1990
Ip Pavlov Higher Medical Institute
Graduated: 1990
Marina Konopleva, Houston TX
Marina Konopleva, Houston TX
Specialties:
Internist
Address:
1515 Holcombe Blvd, Houston, TX 77030
Cddo-Compounds And Combination Therapies Thereof
Cddo-Compounds And Combination Therapies Thereof
US Patent:
2003011, Jun 26, 2003
Filed:
Nov 28, 2001
Appl. No.:
09/998009
Inventors:
Marina Konopleva - Houston TX, US
Michael Andreeff - Houston TX, US
Michael Sporn - Tunbridge VT, US
Michael Andreeff - Houston TX, US
Michael Sporn - Tunbridge VT, US
Assignee:
Board of
International Classification:
A61K038/17
US Classification:
514/012000
Abstract:
CDDO-compounds in combination with other chemotherapeutic agents induce and potentiate cytotoxicity and apoptosis in cancer cell. One class of chemotherapeutic agents include retinoids. Cancer therapies based on these combination therapies are provided. Also provided are methods to treat graft versus host diseases using the CDDO compounds.
Cddo-Compounds And Combination Therapies Thereof
Cddo-Compounds And Combination Therapies Thereof
US Patent:
7795305, Sep 14, 2010
Filed:
Oct 10, 2008
Appl. No.:
12/249588
Inventors:
Marina Konopleva - Houston TX, US
Michael Andreeff - Houston TX, US
Michael B. Sporn - Tunbridge VT, US
Michael Andreeff - Houston TX, US
Michael B. Sporn - Tunbridge VT, US
Assignee:
Board of Regents, The University of Texas System - Austin TX
The Trustees of Dartmouth College - Hanover NH
The Trustees of Dartmouth College - Hanover NH
International Classification:
A61K 31/21
US Classification:
514510, 514310, 514569
Abstract:
CDDO-compounds in combination with other chemotherapeutic agents induce and potentiate cytotoxicity and apoptosis in cancer cell. One class of chemotherapeutic agents include retinoids. Cancer therapies based on these combination therapies are provided. Also provided are methods to treat graft versus host diseases using the CDDO compounds.
Phosphorylation And Regulation Of Akt/Pkb By The Rictor-Mtor Complex
Phosphorylation And Regulation Of Akt/Pkb By The Rictor-Mtor Complex
US Patent:
2010017, Jul 8, 2010
Filed:
Jul 15, 2008
Appl. No.:
12/218629
Inventors:
David M. Sabatini - Cambridge MA, US
Dos D. Sarbassov - Shrewsbury MA, US
Michael Andreeff - Houston TX, US
Marina Konopleva - Houston TX, US
Zhihong Zeng - Houston TX, US
Francis J. Giles - San Antonio TX, US
Dos D. Sarbassov - Shrewsbury MA, US
Michael Andreeff - Houston TX, US
Marina Konopleva - Houston TX, US
Zhihong Zeng - Houston TX, US
Francis J. Giles - San Antonio TX, US
International Classification:
A61K 31/436, C12N 5/00, C12Q 1/02, A61P 35/00
US Classification:
514291, 435375, 435 29
Abstract:
In certain aspects, the invention relates to methods for identifying compounds which modulate Akt activity mediated by the rictor-mTOR complex and methods for treating or preventing a disorder that is associated with aberrant Akt activity.
Combination Therapy With Synthetic Triterpenoids And Gemcitabine
Combination Therapy With Synthetic Triterpenoids And Gemcitabine
US Patent:
2009004, Feb 19, 2009
Filed:
Aug 15, 2008
Appl. No.:
12/192710
Inventors:
Colin Meyer - Frisco TX, US
Michael Andreeff - Houston TX, US
Marina Konopleva - Houston TX, US
Michael Andreeff - Houston TX, US
Marina Konopleva - Houston TX, US
International Classification:
A61K 31/7064, A61P 35/00
US Classification:
514 49
Abstract:
The present invention concerns methods for treating cancer, such as pancreatic cancer, using combination therapies, including the combination of a synthetic triterpenoid, e.g., CDDO-Me, and gemcitabine.